May 21, 2020 / 10:37 PM / 2 months ago

BRIEF-U.S. FDA Approves Kynmobi For Treatment Of "Off" Episodes In Patients With Parkinson's Disease To Sunovion

May 21 (Reuters) - Sumitomo Dainippon Pharma Co Ltd :

* U.S. FDA APPROVES KYNMOBI FOR ACUTE, INTERMITTENT TREATMENT OF “OFF” EPISODES IN PATIENTS WITH PARKINSON’S DISEASE TO SUNOVION PHARMACEUTICALS Source text: (bit.ly/2LNrbwl) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below